Peptide and Anticoagulant Drugs Market Size | COVID-19 Impact Analysis | Forecast to 2027

The global peptide and anticoagulant drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Anticoagulants are blood thinners that prevent or reduce coagulation of blood, prolonging the clotting time. These drugs are used for deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and others. Peptides are long-chain amino acids. The major factor for the growth of the market include the increasing prevalence of chronic diseases and increasing healthcare expenditure.

According to the Centers for Medicare & Medicaid Services (CMS), in 2020, the US health care spending grew 9.7%, reaching $4.1 trillion and a total of $12,530 per person. Additionally, healthcare spending accounted for 19.7% of the nation's Gross Domestic Product (GDP). Furthermore, according to World Health Organization (WHO), the global healthcare expenditure was 9.8% of the world’s GDP in 2018. Further, according to the National Center for Biotechnology Information (NCBI), approximately one in three of all adults suffer from multiple chronic conditions globally in 2018. Moreover, the rising geriatric population is also driving the growth of the market.

To Request a Sample of our Report on Peptide and Anticoagulant Drugs Market: https://www.omrglobal.com/request-sample/peptide-and-anticoagulant-drugs-market

Some major players in the market include Abbott Laboratories, Johnson & Johnson Services, Inc., Bayer AG, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2020, Nacto Pharma launched a Rivaroxban molecule under the brand name RPIGAT. Rivaroxban is an anticoagulant medication used to prevent blood clots.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered-

· By Product

· By Application

• Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

• Competitive Landscape-Abbott Laboratories, Johnson & Johnson Services, Inc., Bayer AG, and Pfizer Inc.,among others.

(Get 15% Discount on Buying this Report)

A full Report of Peptide and Anticoagulant Drugs Market is Available at: https://www.omrglobal.com/industry-reports/peptide-and-anticoagulant-drugs-market

Global Peptide and Anticoagulant Drugs Market Report by Segment

By Product

• Hormonal

• Antibiotic

• ACE Inhibitor

• Antifungal

• Others

By Application

• Diabetes

• Infectious Diseases

• Cancer

• Osteoporosis

• Cardiology

• Gynecology

• Others

Global Peptide and Anticoagulant Drugs Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.